A case of delayed exacerbation of interstitial lung disease after discontinuation of temsirolimus

In conclusion, physicians should be aware of the possibility of temsirolimus-induced ILD not only while the medication is administered, but also even after it is discontinued. It is important to carefully interview the patient and to recognize the value of physiological tests, such as respiratory function tests and blood gas analysis, as well as imaging findings on HRCT.
Source: Respiratory Medicine Case Reports - Category: Respiratory Medicine Source Type: research